- $236.17m
- $170.41m
- $142.10m
Expensify Inc reports results for the quarter ended March 31 - Earnings Summary
Expensify Inc expected to post earnings of 7 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-BridgeBio Pharma, NetApp, Talen Energy
Expensify jumps after quarterly results beat expectations
Expensify Inc reports results for the quarter ended December 31 - Earnings Summary
Expensify Inc expected to post earnings of 7 cents a share - Earnings Preview
Expensify falls after JMP Securities downgrades to 'market perform'
Expensify Inc reports results for the quarter ended in September 30 - Earnings Summary
Expensify Inc expected to post earnings of 6 cents a share - Earnings Preview
Brief: Expensify Pays Down All Debt And Announces Share Repurchase
U.S. STOCKS ON THE MOVE-Revance Therapeutics, Insulet, StepStone
Expensify soars after lifting annual free cash flow forecast
Brief: Expensify - On Aug, 8 Announced That It Reduced Its Debt By $15.0M In July 2024 And Expects To Further Reduce Its Debt By $7.6M In August Of 2024
Expensify Inc reports results for the quarter ended in June - Earnings Summary
Expensify Inc expected to post earnings of 4 cents a share - Earnings Preview
Expensify Inc expected to post earnings of 5 cents a share - Earnings Preview
Expensify Inc reports results for the quarter ended in December - Earnings Summary
Brief: Expensify, Inc. Q3 revenue USD 36.494 million
Expensify Inc expected to post earnings of 2 cents a share - Earnings Preview